Economic evaluation of implementation strategies in health care

Implementation Science

Johan L Severens²  Ties Hoomans¹ 

[1] Section of Hospital Medicine, Department of Medicine, University of Chicago, Chicago, USA;Institute of Medical Technology Assessment (iMTA), Erasmus University Rotterdam, Rotterdam, The Netherlands

关键词: Decision-making;    Economic evaluation;    Cost of implementation;    Implementation strategies;   

Others  :  1139458
DOI  :  10.1186/s13012-014-0168-y

 received in 2014-08-08, accepted in 2014-09-18,  发布年份 2014

【 摘 要 】

Economic evaluations can inform decisions about the efficiency and allocation of resources to implementation strategies—strategies explicitly designed to inform care providers and patients about the best available research evidence and to enhance its use in their practices. These strategies are increasingly popular in health care, especially in light of growing concerns about quality of care and limits on resources. But such concerns have hardly motivated health authorities and other decision-makers to spend on some form of economic evaluation in their assessments of implementation strategies. This editorial addresses the importance of economic evaluation in the context of implementation science—particularly, how these analyses can be most efficiently incorporated into decision-making processes about implementation strategies.

【 授权许可】

   
2014 Hoomans and Severens; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, DeCristofaro A, Kerr EA: Glyn the quality of health care delivered to adults in the United States. N Engl J Med 2003, 348(26):2635-2645.
• [2]Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L, Whitty P, Eccles MP, Matowe L, Shirran L, Wensing M, Dijkstra R, Donaldson C: Effectiveness and efficiency of guideline dissemination and implementation strategies.Health Technol Assess 2004, 8(6):iii–iv, 1–72
• [3]Grol R, Wensing M, Eccles M, Davis D: Improving Patient Care. The Implementation of Change in Clinical Practice. 2nd edition. Wiley-Blackwell, Chichester West Sussex; 2013.
• [4]Grol R, Bosch MC, Hulscher ME, Eccles MP, Wensing M: Planning and studying improvement in patient care: the use of theoretical perspectives. Milbank Q 2007, 85(1):93-138.
• [5]Davies P, Walker AE, Grimshaw JM: A systematic review of the use of theory in the design of guideline dissemination and implementation strategies and interpretation of the results of rigorous evaluations. Implement Sci 2010, 5:14. doi: 10.1186/1748-5908-5-14 BioMed Central Full Text
• [6]Vale L, Thomas R, MacLennan G, Grimshaw J: Systematic review of economic evaluations and cost analyses of guideline implementation strategies. Eur J Health Econ 2007, 8(2):111-121.
• [7]Hoomans T, Evers S, Ament A, Hübben M, Van der Weijden T, Grimshaw J, Severens J: The methodological quality of economic evaluations of guideline implementation into clinical practice: a systematic review of empiric studies. Value Health 2007, 10(4):305-316.
• [8]Mason J, Wood J, Freemantle N: Designing evaluations of interventions to change professional practice. J Health Serv Res Policy 1999, 4(2):106-111. Erratum in: J Health Serv Res Policy 1999 Jul;4(3):192
• [9]Sculpher M: Evaluating the cost-effectiveness of interventions designed to increase the utilization of evidence-based guidelines. Fam Pract 2000, 17(Suppl 1):S26-S32.
• [10]McIntosh E: Economic evaluations of guideline implementation strategies. In Changing Professional Practice: Theory and Practice of Clinical Guidelines Implementation. Edited by Thorsen T, Makela M. Danish Institute for Health Services Research and Development, Copenhagen; 1999.
• [11]Kroese ME, Severens JL, Schulpen GJ, Bessems MC, Nijhuis FJ, Landewé RB: Specialized rheumatology nurse substitutes for rheumatologists in the diagnostic process of fibromyalgia: a cost-consequence analysis and a randomized controlled trial. J Rheumatol 2011, 38(7):1413-1422.
• [12]Mason JM, Freemantle N, Gibson JM, New JP: SPLINT trial: Specialist nurse-led clinics to improve control of hypertension and hyperlipidemia in diabetes: economic analysis of the SPLINT trial. Diabetes Care 2005, 28(1):40-46.
• [13]Scheeres K, Wensing M, Bleijenberg G, Severens J: Implementing cognitive behaviour therapy for chronic fatigue syndrome in mental health care: a costs and outcomes analysis. BMC Health Serv Res 2008, 8:175. BioMed Central Full Text
• [14]Walker S, Mason AR, Claxton K, Cookson R, Fenwick E, Fleetcroft R, Sculpher M: Value for money and the quality and outcomes framework in primary care in the UK NHS. Br J Gen Pract 2010, 60(574):e213-e220.
• [15]Hoomans T, Abrams KR, Ament AJHA, Evers SMAA, Severens JL: Modelling the value for money of changing clinical practice change: a stochastic application in diabetes care. Med Care 2009, 47(10):1053-1061.
• [16]Choudhry NK, Avorn J, Glynn RJ, Antman EM, Schneeweiss S, Toscano M, Reisman L, Fernandes J, Spettell C, Lee JL, Levin R, Brennan T, Shrank WH: Post-Myocardial Infarction Free Rx Event and Economic Evaluation (MI FREEE) trial. Full coverage for preventive medications after myocardial infarction. N Engl J Med 2011, 365(22):2088-2097.
• [17]Mortimer D, French SD, McKenzie JE, O’Connor DA, Green SE: Economic evaluation of active implementation versus guideline dissemination for evidence-based care of acute low-back pain in a general practice setting. PLoS One 2013, 8(10):e75647.
• [18]Gillespie P, O’Shea E, Hara MCO, Dinneen SF: Cost effectiveness of group follow-up after structured education for type 1 diabetes: a cluster randomised controlled trial. Trials 2014, 15(1):227. BioMed Central Full Text
• [19]Martens JD, Werkhoven MJ, Severens JL, Winkens RA: Effects of a behaviour independent financial incentive on prescribing behaviour of general practitioners. J Eval Clin Pract 2007, 13(3):369-373.
• [20]Fenwick E, Claxton K, Sculpher M: The value of implementation and the value of information: combined and uneven development. Med Decis Making 2008, 28:21-32.
• [21]Hoomans T, Fenwick EA, Palmer S, Claxton K: Value of information and value of implementation: application of an analytic framework to inform resource allocation decisions in metastatic hormone-refractory prostate cancer. Value Health 2009, 12(2):315-324.
• [22]Hoomans T, Severens JL, Evers SMAA, Ament AJHA: Value for money in changing clinical practice: should decisions about guidelines and implementation strategies be made sequentially or simultaneously? Med Decis Making 2009, 29:207-216.